Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Equity Average (2018 - 2025)

Health Catalyst (HCAT) has disclosed Equity Average for 8 consecutive years, with $339.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Average fell 4.57% year-over-year to $339.7 million, compared with a TTM value of $339.7 million through Sep 2025, down 4.57%, and an annual FY2024 reading of $366.1 million, down 7.55% over the prior year.
  • Equity Average was $339.7 million for Q3 2025 at Health Catalyst, down from $362.2 million in the prior quarter.
  • Across five years, Equity Average topped out at $535.7 million in Q4 2021 and bottomed at $272.4 million in Q2 2021.
  • Average Equity Average over 5 years is $391.5 million, with a median of $374.7 million recorded in 2023.
  • The sharpest move saw Equity Average soared 86.08% in 2021, then fell 19.26% in 2022.
  • Year by year, Equity Average stood at $535.7 million in 2021, then dropped by 19.26% to $432.5 million in 2022, then decreased by 13.37% to $374.7 million in 2023, then dropped by 3.88% to $360.1 million in 2024, then dropped by 5.66% to $339.7 million in 2025.
  • Business Quant data shows Equity Average for HCAT at $339.7 million in Q3 2025, $362.2 million in Q2 2025, and $371.0 million in Q1 2025.